Personalizing Chemotherapy
S C I E N T I S T S AT R U T G E R S U N I V E R S I T Y have developed a portable
device that incorporates biosensors and artificial intelligence to help
predict whether individual cancer patients are likely to benefit from
particular chemotherapy drugs.
Using the device, researchers passed cancer cells treated with varying
concentrations of drugs through a fluidic hole. Changes in the cells'
electrical properties quickly revealed whether the cells were still alive,
according to a news release from Rutgers.
The device "can predict whether patients will respond positively to tar-
geted cancer therapy," says senior author Mehdi Javanmard, an Assistant
Professor in the Department of Electrical and Computer Engineering in
the School of Engineering at Rutgers University–New Brunswick.
The scientists say the device could enhance personalization of treatment
and management of the disease.
Their findings were published in Microsystems & Nanoengineering. n
PRODUCT SPOTLIGHT
BY STEVE BARRETT
1 0
